Compare AHMA & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AHMA | DXR |
|---|---|---|
| Founded | 2007 | 1970 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.3M | 59.0M |
| IPO Year | 2024 | 1995 |
| Metric | AHMA | DXR |
|---|---|---|
| Price | $1.37 | $10.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 34.3K | 2.9K |
| Earning Date | 05-22-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | $180.72 | ★ $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.76 | $8.56 |
| 52 Week High | $39.50 | $14.76 |
| Indicator | AHMA | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 39.12 | 44.35 |
| Support Level | $1.03 | $9.64 |
| Resistance Level | $1.88 | $12.08 |
| Average True Range (ATR) | 0.10 | 0.25 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 21.43 | 32.71 |
Ambitions Enterprise Management Co LLC, through its subsidiaries in the UAE, operates as a tour operator, travel agency, and event planning and management services provider. It provides two lines of services, namely, MICE management, a comprehensive coordination and organization of events, and one-stop tourism, a comprehensive travel product that is designed to provide tourists with all the necessary components of a trip in a single and convenient package, which typically include transportation, accommodations, meals, and guided tours or activities.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.